Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Hyponatraemia

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Seizure, cardiorespiratory arrest, persistent vomiting, coma or markedly reduced consciousness with hyponatraemia requires immediate senior-led hypertonic saline treatment in a closely monitored setting. Follow the 2022 Society for Endocrinology bolus pathway, aim initially for symptom improvement and an approximately 5 mmol/L sodium rise, and prepare actively to stop or reverse overcorrection.

Synopsis

Treat cerebral symptoms immediately, classify hypotonic hyponatraemia physiologically and prevent osmotic injury from uncontrolled sodium correction.

  • Base emergency treatment on neurological symptoms and their likely relation to hyponatraemia, not on the sodium concentration alone; profound chronic hyponatraemia may be asymptomatic while a rapid moderate fall can cause cerebral oedema.
  • Confirm tonicity: hyperglycaemia causes translocational hyponatraemia, and very high lipid or protein can create measurement artefact with some laboratory methods.
  • For severe or moderately severe symptoms, the Society for Endocrinology recommends 150 mL of 3% sodium chloride over 20 minutes, repeated according to the measured response in a suitable monitored environment.
  • Target a 5 mmol/L rise during the first hour, then limit total increase to no more than 10 mmol/L in the first 24 hours and 8 mmol/L per 24 hours thereafter.
  • Obtain paired serum osmolality, urine osmolality and urine sodium early, but do not delay emergency hypertonic treatment to complete aetiological classification.
  • Exclude adrenal insufficiency and clinically important hypothyroidism before calling euvolaemic hypotonic hyponatraemia syndrome of inappropriate antidiuresis.
  • A sudden water diuresis after volume or cortisol restoration can make sodium rise much faster than predicted; urine output is an early warning signal for overcorrection.
  • Vaptans are not recommended for severe or moderately severely symptomatic presentations; cause-specific longer-term treatment requires endocrine, renal and local formulary governance.

Key red flags

Severe cerebral symptoms

Seizure, cardiorespiratory arrest, persistent vomiting, coma or Glasgow Coma Scale at or below eight defines the highest emergency category in Society guidance.

Moderately severe syndrome

Confusion, headache or nausea without vomiting may still reflect cerebral oedema and warrants immediate experienced assessment and the symptomatic pathway.

Endocrine mimic

Hypotension, weight loss, hyperkalaemia, hypoglycaemia or steroid exposure raises adrenal insufficiency; pituitary disease can lack hyperkalaemia and still cause dangerous cortisol deficiency.

Overcorrection warning

A brisk new dilute urine output, rapidly improving cause or unexpectedly large sodium increment predicts aquaresis and demands immediate intensified monitoring and senior action.

Investigation priorities

01
Repeat serum sodium on a consistent platformFirst step

Confirm the value and measure correction without inter-method variation obscuring small but important changes.

Management branches

RescueTreat symptomatic cerebral oedema

Hyponatraemia accompanies severe or moderately severe neurological symptoms without a more convincing immediate explanation.

  1. Use ABCDE, bedside glucose and seizure care, call an experienced senior clinician and transfer to an environment able to deliver hypertonic saline with rapid sodium measurement.
  2. Give 150 mL 3% sodium chloride or locally equivalent hypertonic solution over 20 minutes, remeasure sodium using the same platform and repeat as the Society algorithm directs towards a 5 mmol/L first-hour rise.
  3. Once symptoms improve or the initial target is reached, stop hypertonic treatment, begin cause-specific care and enforce the subsequent 24-hour correction limits.

Key medicines

Hypertonic sodium chloride 3%For severe or moderately severely symptomatic adult hyponatraemia, Society for Endocrinology guidance uses 150 mL intravenously over 20 minutes, rechecking sodium and repeating up to the algorithm limit to achieve about a 5 mmol/L first-hour rise.This is a senior-supervised high-risk prescription requiring a close-monitoring area, consistent sodium assay and documented stop limits. Avoid continuous unstructured infusion, vaptans in this presentation and formula-led dosing that ignores dynamic urine water loss.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Society for Endocrinology 2022 hyponatraemia guidanceCurrent UK symptom categories, 3% saline bolus, correction limits and overcorrection response.
  • NICE CKS hyponatraemia managementCurrent UK diagnostic and cause-specific community and hospital management context.
  • NICE CG174 intravenous fluid recommendationsAdult fluid assessment, prescribing, reassessment and electrolyte governance.
  • Society for Endocrinology guidance hubOfficial current index retaining the 2022 severe symptomatic hyponatraemia document.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom